Viewing Study NCT01119859


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2025-12-26 @ 1:25 PM
Study NCT ID: NCT01119859
Status: COMPLETED
Last Update Posted: 2013-02-11
First Post: 2010-04-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis
Sponsor: Hoffmann-La Roche
Organization: